Marian Sobhy Waheeb Azer | Pharmaceutical Sciences | Innovative Research Award

Innovative Research Award

Marian Sobhy Waheeb Azer — Misr University for Science & Technology, Egypt

Marian Sobhy Waheeb Azer
Affiliation Misr University for Science & Technology
Country Egypt
Subject Area Pharmaceutical Sciences
Event International Top Pharmaceutical Awards
ORCID 0000-0003-1072-9893

Marian Sobhy Waheeb Azer is a researcher associated with pharmaceutical sciences whose ORCID record lists work on drug delivery, formulation development, and pharmacokinetic evaluation. The documented topics include a lamotrigine self-nanoemulsifying delivery system and a ciclopirox olamine emulgel formulation. These subjects reflect practical research interests in dosage-form design, pharmaceutical characterization, and the investigation of drug delivery performance. This article summarizes the available profile information and its relevance to the Innovative Research Award without assuming unverified bibliometric indicators or award outcomes.[1][2]

Abstract

This profile reviews the pharmaceutical research themes documented in Marian Sobhy Waheeb Azer’s ORCID record. The listed publications concern formulation development and drug delivery, including a solid self-nanoemulsifying system for lamotrigine and a topical emulgel containing ciclopirox olamine. These topics are relevant to pharmaceutical formulation, characterization, and evaluation of drug delivery systems. The available record supports a focused account of these research activities, but does not independently establish citation totals, an h-index, or an official award decision.[1][2]

Keywords

Pharmaceutical sciences; drug delivery systems; lamotrigine; self-nanoemulsifying drug delivery; pharmacokinetics; ciclopirox olamine; emulgel formulation; pharmaceutical characterization; formulation research; innovative research.

Introduction

Pharmaceutical research connects the design of dosage forms with the assessment of their properties and potential performance. Delivery-system development can investigate how formulation components influence drug solubilization, release, and absorption, while topical formulations address the requirements of local administration. Azer’s documented work sits within these broad areas. The available publication metadata provides a basis for describing the research topics, although detailed experimental results should be taken from the original articles rather than inferred from titles alone.[1][2]

Research Profile

The supplied ORCID profile identifies Marian Sobhy Azer and lists two research works. One is a 2020 journal article in Drug Design, Development and Therapy on the development, characterization, and in-vivo pharmacokinetic study of a lamotrigine solid self-nanoemulsifying drug delivery system. The other concerns the development and characterization of ciclopirox olamine emulgel for topical drug delivery, listed as published in 2014. The profile does not provide verified Scopus author metrics in the supplied document.[1][2]

Research Contributions

The lamotrigine study addresses a formulation approach designed to support drug delivery and includes characterization and in-vivo pharmacokinetic evaluation in its stated scope. Such work connects pharmaceutical development with the measurement of drug disposition, although specific outcomes require consultation of the full publication. The topical emulgel work focuses on a formulation containing ciclopirox olamine, illustrating a separate dosage-form application. Together, the listed topics show engagement with both systemic delivery research and topical formulation development.[1][2]

Publications

The ORCID profile lists two publications related to pharmaceutical sciences. One focuses on the development and evaluation of a lamotrigine drug delivery system, while the other examines the formulation and characterization of ciclopirox olamine emulgel for topical drug delivery.[1][2]

Research Impact

The documented subjects are relevant to formulation scientists and pharmaceutical researchers investigating delivery strategies and dosage-form characteristics. However, research impact should be assessed using verified evidence such as citation records, independent adoption, reproducibility, and influence on subsequent work. Citation counts and h-index values are not present in the supplied ORCID document, so no numerical impact claim is made here. Further evaluation can use indexed publication records and the full-text articles.[1][3]

Award Suitability

The listed work provides subject-matter relevance to an Innovative Research Award in pharmaceutical sciences, particularly through formulation development and drug delivery investigations. A fair assessment would examine originality, methodological quality, reproducibility, publication integrity, practical significance, and the candidate’s specific contribution to each study. The information presented here is a profile summary, not confirmation of nomination, selection, or receipt of an award. Final eligibility and recognition must be verified with the award organizer.[4]

Conclusion

Marian Sobhy Waheeb Azer’s supplied ORCID record documents research related to lamotrigine delivery systems and ciclopirox olamine topical formulation. These subjects are pertinent to pharmaceutical formulation and evaluation. The record offers a starting point for academic recognition, while a complete assessment requires the original articles, verified bibliometric data, and evidence of individual research contributions. Readers should consult the linked primary sources for publication details and the official award website for current event information.

References

  1. Azer, M. S. (2020). Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System. Drug Design, Development and Therapy. DOI: 10.2147/DDDT.S263898.
  2. Azer, M. S. (2014). Development and Characterization of Ciclopirox Olamine Emulgel for Topical Drug Delivery. Inventi Impact: Pharm Tech. Publication details transcribed from the supplied ORCID profile. https://inventi.in/journal/article/1/7319/Inventi%20Impact:%20Pharm%20Tech/Pharmaceutical
  3. ORCID. (n.d.). Marian Sobhy Azer: Researcher record and works. https://orcid.org/0000-0003-1072-9893.
  4. International Top Pharmaceutical Awards. (n.d.). Official award website. Award eligibility and recognition details should be confirmed with the organizer. https://toppharmaceutical.org/.

Shweta Patel | Women Researcher Award | Pharmaceutical

Women Researcher Award

Shweta Patel — Gokul Global University, India

Shweta Patel
Affiliation Gokul Global University
Country India
Scopus ID 59600471600
Documents 17
Citations 25
h-index 3
Subject Area Pharmaceutical
Event International Top Pharmaceutical Awards
ORCID 0000-0002-8893-3248

Shweta Patel is a researcher associated with Gokul Global University, India, whose documented scholarly record includes pharmaceutical and medicinal chemistry research. Her recent work includes heterocyclic compound synthesis, antimicrobial evaluation, antioxidant studies, and ADME-oriented investigations. The available research record also identifies contributions involving green synthesis and computational assessment of chemical compounds.[1] :contentReference[oaicite:0]{index=0}

Abstract

The research profile of Shweta Patel reflects activity across pharmaceutical chemistry, medicinal chemistry, chemical synthesis, antimicrobial research, and computational drug-development approaches. Available records document studies involving pyran, oxadiazole, thiazolidinone, chromene, quinoline, and related heterocyclic frameworks. Several publications combine synthesis and characterization with biological or ADME-oriented evaluation, providing a multidisciplinary basis for pharmaceutical research.[2]

Keywords

Pharmaceutical Chemistry; Medicinal Chemistry; Drug Discovery; Heterocyclic Chemistry; Antimicrobial Research; Antioxidant Activity; ADME Prediction; Green Synthesis; Chemical Synthesis; Pharmaceutical Innovation.

Introduction

Pharmaceutical research increasingly integrates synthetic chemistry with biological screening and computational approaches to identify compounds with potentially useful pharmacological characteristics. Patel’s documented publications reflect this interdisciplinary pattern, particularly through investigations of heterocyclic derivatives and their antimicrobial or antioxidant properties. The research record also includes studies applying ADME prediction and green synthetic methodologies to pharmaceutical chemistry problems.[3]

Research Profile

The available Scopus-linked record identifies Shweta Patel with Scopus Author ID 59600471600, while the supplied ORCID record identifies 33 works across articles, book chapters, and other research outputs. The documented publication history spans at least 2023–2026 and includes journals such as the Journal of Pharmaceutical Innovation, Russian Journal of General Chemistry, Russian Journal of Organic Chemistry, and related scientific publications.[4]

Research Contributions

A recurring research theme is the design and synthesis of heterocyclic compounds followed by structural characterization and biological evaluation. Recent records include pyrazole–oxadiazole–thioacetamide hybrids, 1,8-naphthyridine–thiazolidinone derivatives, chromene–thiazolidinedione hybrids, and oxadiazole thioacetamide derivatives. These studies demonstrate an emphasis on connecting molecular design with antimicrobial activity and ADME-related assessment.[5]

Publications

The publication portfolio includes recent journal articles and earlier studies in synthetic and pharmaceutical chemistry. Documented examples include work on 2H-pyran derivatives, 1,3,4-oxadiazole derivatives, modified 2-oxochromane compounds, 1,4-dihydropyrano[2,3-c]pyrazoles, and 2-amino-4H-pyrans. The record also contains research on environmental applications of functionalized nanoparticles and pharmaceutical sedation comparisons.[4]

Research Impact

The supplied profile records 17 documents, 25 citations, and an h-index of 3 for the award profile. These metrics provide quantitative indicators of scholarly output and citation activity, although bibliometric values can change as databases are updated. The broader ORCID-linked record indicates additional works and research outputs beyond the selected metrics supplied for this recognition page.[4]

Award Suitability

The documented combination of pharmaceutical chemistry publications, heterocyclic synthesis, antimicrobial evaluation, antioxidant investigations, and ADME-focused research provides a clear scholarly basis for consideration within a pharmaceutical research recognition context. The record contains multiple peer-reviewed journal articles with DOI identifiers, allowing individual publications to be independently located and evaluated. Award consideration should be based on the applicable criteria and verified supporting documentation. [4]

Conclusion

Shweta Patel’s documented research activity encompasses several interconnected areas of pharmaceutical and medicinal chemistry, with particular emphasis on synthetic heterocyclic chemistry and biological evaluation. Her publication record includes recent DOI-indexed studies as well as earlier research on green synthesis and antimicrobial compounds. The available identifiers and publication records provide a basis for further scholarly verification and recognition assessment.

References

 

  1. Elsevier. (n.d.). Scopus author details: Shweta Patel, Author ID 59600471600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59600471600
  2. Patel, S. A. (2026). Development of a Novel 1,8-Naphthyridine–Thiazolidinone Derivative: Synthesis, Spectral Characterization, Antimicrobial Profiling, and ADME Prediction. Journal of Pharmaceutical Innovation. https://doi.org/10.1007/s12247-026-10426-z
  3. Patel, S. (2026). Structure–Activity Relationship and ADME-Guided Optimization of 4H-Chromene-3-Carbonitrile Derivatives as Promising Antimicrobial Agents. Research Square. https://doi.org/10.21203/rs.3.rs-8718836/v1
  4. Patel, S. (2026). Design and Synthesis of Pyrazole–Oxadiazole–Thioacetamide Hybrids with Antimicrobial and Antioxidant Properties. Journal of Pharmaceutical Innovation. https://doi.org/10.1007/s12247-026-10720-w
  5. Patel, S. (2026). Molecular hybridization approach toward quinoline–thiazolidinedione derivatives: synthesis, DPPH radical scavenging activity, and ADME prediction. Journal of the Iranian Chemical Society. https://doi.org/10.1007/s13738-026-03636-2

Gul Wali Khan | Medicinal Chemistry | Research Excellence Award

Mr. Gul Wali Khan | Medicinal Chemistry | Research Excellence Award

Research Assistant | Vorozhtsov Novosibirsk Institute of Organic Chemistry | Pakistan

Mr. Gul Wali Khan is a Research Assistant in organic chemistry at the Novosibirsk Institute of Organic Chemistry, specializing in organometallic synthesis and characterization. He holds advanced degrees in chemistry with a strong focus on organic and coordination chemistry, including research on ferrocene-based bimetallic complexes and ligand design. His professional experience includes extensive laboratory research involving experimental design, spectroscopic characterization, data analysis, and collaborative scientific reporting, alongside prior academic roles in teaching and mentoring chemistry students. His research focuses on the synthesis, structural analysis, and biological evaluation of metal-based complexes, contributing to the advancement of organometallic chemistry with applications in antimicrobial studies and material science. He has authored peer-reviewed publications in reputable journals and is actively engaged in ongoing research projects, demonstrating consistent scholarly output. His contributions reflect a commitment to high-quality research, interdisciplinary collaboration, and growing academic impact, positioning him as a promising candidate for recognition in research excellence.

Citation Metrics (Google Scholar)

11
8
5
2
0

1

1

1

Citations

Documents

h-index

 


Featured Publications

Alptug Atila | Pharmaceutical Analysis | Best Researcher Award

Prof. Alptug Atila | Pharmaceutical Analysis | Best Researcher Award

Ataturk University | Turkey

Prof. Alptug Atila is a distinguished scholar in the field of analytical chemistry with a robust academic foundation built at Ataturk University, where he pursued undergraduate studies in chemistry, followed by postgraduate and doctoral research specializing in analytical chemistry. Over the years, he has attained profound expertise across diverse research areas, including atomic mass spectrometry, atomic and molecular spectroscopy, bioanalytical methods, pharmaceutical analysis, chromatographic analysis, molecular mass spectroscopy, and separation techniques. His work also spans natural sciences, electromagnetic methods, sample preparation, and spectroscopical methods, reflecting an interdisciplinary approach to solving complex analytical challenges.Currently serving as a professor in the Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences at Ataturk University, Prof. Atila has made significant contributions to academia and research. His administrative roles, such as Assistant Manager of Research and Application Center, further underscore his leadership in promoting innovative research and laboratory practices. Equipped with certifications in Quality Management and Good Laboratory Practice (GLP) from the Turkish Accreditation Agency (TÜRKAK), he combines technical excellence with rigorous quality standards.Prof. Atila’s prolific research output is evident in his extensive list of publications across prestigious journals indexed in SCI, SSCI, and AHCI. Some of his remarkable works include Analyzing Quinoa Seeds: LC–MS/MS and GC–MS/MS Approaches for Identifying a Nutrient-Rich Functional Food in Alzheimer’s and Diabetes Care, A Comparative Evaluation of Salivary and Plasma Bisphenol-A Levels in Patients Released from Four Different Orthodontic Appliances: Ultra-Performance Liquid Chromatography-Mass Spectrometry Study, and Comprehensive Analysis of Elemental and Metabolite Composition in Boraginaceae Species from Türkiye. He has also advanced pharmaceutical analytics through studies such as Method Development and Validation for Determination of N-Nitrosamines in Pharmaceutical Preparations by LC-MS/MS: Application to Extractables and Leachables Studies and Changes of Plasma Amino Acid Levels and Metabolic Pathways in Isotretinoin Therapy: Insights into Managing Acne Vulgaris Side Effects.

Profile: Scopus

Featured Publications

Atila A., Akman T. Ç., Yazıcı M.
Changes of plasma amino acid levels and metabolic pathways in isotretinoin therapy: insights into managing acne vulgaris side effects. Archives of Dermatological Research. Citations: 0

Atila A., Öner S., Kadı A., Tekman E., Kararenka C., Özer E. B., Ergin K. N., Yuca H., Arslan M. E., Duman R., Acarşahin A., et al.
Morphological, anatomical, and bioactive properties of Hypericum scabrum L.: effects on diabetes mellitus, Alzheimer’s disease, and HDFa fibroblasts and U87-MG cancer cells. Protoplasma. Citations: 2

Atila A., Halici H., Un H., Celik S., Karakoy Z., Bayraktutan Z., Ozlu C., Cadirci E., Halici Z., Mercantepe F.
Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells. Protein Journal. Citations: 0

Atila A., Coban F., Yuca H., Aydin B., Tosun M., Yazıcı A., Karakaya S., Tan M., Ozer H.
Analyzing Quinoa Seeds: LC–MS/MS and GC–MS/MS Approaches for Identifying a Nutrient-Rich Functional Food in Alzheimer’s and Diabetes Care. Chemistry and Biodiversity. Citations: 0

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Dr. Awatef Sassi, Faculty of medicine of sousse, Tunisia

Dr. Awatef Sassi 🧬🔬 is a distinguished postdoctoral researcher at the Faculty of Medicine of Sousse, specializing in cardiovascular and metabolic research. She earned her Ph.D. in Biological Sciences (2018) from the Faculty of Science of Bizerte, following a Master’s in Vascular Diseases Biology (2011) and a Medical Biotechnology degree (2008). Dr. Sassi has contributed significantly to scientific advancements, securing a patent on anti-hypertensive properties of Rosmarinus officinalis and publishing in high-impact journals. She is actively involved in mentoring medical theses and conducting innovative research in biophysics and applied toxicology. 🌿📊

Publication Profile

Orcid

Education

Dr. Awatef Sassi is a distinguished scholar in biological sciences 🧬, biotechnology 🏥, and vascular diseases ❤️. With a Ph.D. in Biological Sciences 🎓, a Master’s in Vascular Disease Biology, and a Medical Biotechnology degree, she has demonstrated an unwavering commitment to scientific research 🔬. Her extensive expertise spans innovative biotechnological applications and advancements in vascular health, contributing significantly to the medical and scientific communities. Dr. Sassi’s dedication to excellence and groundbreaking research continues to shape the future of biotechnology and vascular medicine, making her a respected figure in the field 🌟.

Experience 

Dr. Awatef Sassi’s postdoctoral research at the Faculty of Medicine in Sousse 🏥 has focused on cardio-pulmonary interactions 💓💨 and biophysics ⚛️, making significant contributions to biomedical sciences. As a dedicated mentor, she has supervised multiple medical theses 📚, showcasing her leadership in academia. Her patented innovation 🏅 on the antihypertensive activity of Rosmarinus officinalis 🌿 (TN 2023/0143) highlights groundbreaking research with potential clinical impact in hypertension treatment 💊. Through her pioneering work, Dr. Sassi continues to advance medical science, bridging research and practical healthcare solutions for improved cardiovascular health ❤️.

Professional Development

Dr. Awatef Sassi is a dedicated educator and researcher 🎓🔬, with extensive experience as a lecturer in analytical chemistry ⚗️. Her involvement in postgraduate training 📚 has strengthened expertise in HPLC/UPLC 💉, mass spectrometry 🧪, and data analysis (SPSS) 📊. Through her teaching and mentorship, she equips students and researchers with essential analytical and computational skills, fostering scientific excellence. Dr. Sassi’s commitment to professional development ensures that future scientists gain hands-on experience in advanced laboratory techniques, making a lasting impact in biotechnology, pharmacology, and medical sciences 🏥🌿.

Research Focus

Dr. Awatef Sassi’s research primarily focuses on phytomedicine 🌿, clinical nutrition 🥗, cardiovascular health ❤️, and pharmaceutical sciences 💊. Her work explores the therapeutic potential of medicinal plants like Rosmarinus officinalis and Nitraria retusa for conditions such as hypertension, obesity, and lipid disorders. Additionally, she has contributed to cardiovascular interventions 🏥, dermatological formulations, and transfusion medicine 🩸. Her studies include randomized clinical trials, pilot studies, and formulation research, highlighting her interdisciplinary approach to natural product-based therapy and clinical pharmacology. Her work significantly impacts personalized medicine, preventive healthcare, and alternative treatment strategies.

Publication Top Notes

The Effect of Rosmarinus officinalis L Infusion Supplementation on Blood Pressure Among Healthy Volunteers and Grade 1 Hypertensive Patients

Antiobesity and Hypolipidemic Potential of Nitraria retusa Extract in Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults

Distal radial approach versus conventional radial approach: a comparative study of feasibility and safety

Formulation and evaluation of topical halofuginone gel using a novel <I>ex vivo</i> model

RHD genotyping and its implication in transfusion practice